The attendee will be able to:

1. Describe two (2) benefits each for the clinical site, sponsor and patient of a direct to patient trial.
2. Identify at least two (2) risks for sponsors conducting direct to patient trials and develop effective mitigation strategies for these risks.
3. Identify how use of Central Pharmacies can support delivery of medication closer to the patient thus minimizing waste.